An Akero Therapeutics drug in development for the fatty liver disease MASH now has clinical ... One potential risk of the FGF21 analog drug class is bone loss. The EFX Phase 2 results show a ...

A study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly ... complications of liver disease and an 80% lower risk of ...

Osteoporosis is a disease in which bone resorbs faster than it is formed, gradually weakening its structure over time and ...

A new global report highlighting the urgent action required to prevent further loss of animal and plant life reveals a need to connect more with nature. The Transformative Change Report led and ...

Researchers have combined injections of a novel hydrogel with systemic osteoporosis drugs in rats, achieving rapid local increases in bone density. The results offer hope for future fracture ...

Yes, because bone broth is naturally high in protein and low in calories, it can potentially help with weight management or loss ... heart disease or kidney disease. Always talk to your doctor ...

Gwyneth Paltrow is known for her commitment to wellness. But in 2010, the Oscar-winning actress revealed a surprising health diagnosis at just 37-osteopenia. This condition leads to lower-than-normal ...

Robert Kennedy Jr promised to reverse America’s chronic disease epidemic and rejected accusations that he is against vaccines, during a combative confirmation hearing to become Donald Trump’s ...

FGF1, FGF2 and FGF4 have been studied in clinical trials for the treatment of cardiovascular disease. The results of most of these trials have been unclear. However, some promising prospects remain.